Back to Search Start Over

Should we suspect primary aldosteronism in patients with hypokalaemic rhabdomyolysis? A systematic review.

Authors :
Díaz-López EJ
Villar-Taibo R
Rodriguez-Carnero G
Fernandez-Pombo A
Garcia-Peino R
Blanco-Freire MN
Pena-Dubra A
Prado-Moraña T
Fernández-Xove I
Pérez-Béliz E
Cameselle-Teijeiro JM
Hermida-Ameijeiras A
Martinez-Olmos MA
Source :
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Sep 22; Vol. 14, pp. 1257078. Date of Electronic Publication: 2023 Sep 22 (Print Publication: 2023).
Publication Year :
2023

Abstract

Severe hypokalaemia causing rhabdomyolysis (RML) in primary aldosteronism (PA) is a rare entity, and only a few cases have been reported over the last four decades. This systematic review and case report aims to gather all published data regarding a hypokalaemic RML as presentation of PA in order to contribute to the early diagnosis of this extremely rare presentation. With the use of PubMed Central, EMBASE, and Google Scholar, a thorough internet-based search of the literature was conducted to identify articles and cases with RML secondary to hypokalaemia due to PA between June 1976 and July 2023. The case study concerns a 68-year-old male patient with hypokalaemic RML at presentation of PA. In the systematic review of the literature, 37 cases of RML secondary to hypokalaemia due to PA have been reported to date. In summary, the median age was 47.5 years, the male/female ratio was 17/21, all patients presented symptoms (weakness and/or myalgia), all the patients were hypertensive, and only four patients had complications with acute kidney injury (AKI). Although PA rarely presents with RML, it should be suspected when marked hypokalaemia and hypertension are also present. Early detection and management are essential to reduce the frequency of manifestations such as AKI.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2023 Díaz-López, Villar-Taibo, Rodriguez-Carnero, Fernandez-Pombo, Garcia-Peino, Blanco-Freire, Pena-Dubra, Prado-Moraña, Fernández-Xove, Pérez-Béliz, Cameselle-Teijeiro, Hermida-Ameijeiras and Martinez-Olmos.)

Details

Language :
English
ISSN :
1664-2392
Volume :
14
Database :
MEDLINE
Journal :
Frontiers in endocrinology
Publication Type :
Academic Journal
Accession number :
37810894
Full Text :
https://doi.org/10.3389/fendo.2023.1257078